We are live on ! Find out more
Catalys Pacific

Catalys Pacific Portfolio holdings

AUM $210M Turnover 0%
1-Year Est. Return 33.18%
This Fund
S&P 500
This Quarter Est. Return
-8.55%
1 Year Est. Return
-33.18%
3 Year Est. Return
+188.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$210M
AUM Growth
-$19.7M
Cap. Flow
+$820K
Cap. Flow %
0.39%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
1
Closed
–
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.8 years
Top 20 Avg Time Held
2.8 years

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$3.66M

Top Sells

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MLYS icon
1
Mineralys Therapeutics
MLYS
$1.36B
$196M 93.45%
7,799,518
-104,320
-1% -$2.84M
2023 Q4
11 quarters
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$427M
$13.7M 6.55%
1,882,039
+388,185
+26% +$3.66M
2023 Q4
11 quarters

Similar funds

Index Venture Growth Associates V
Index Venture Growth Associates V St. Helier, Jersey $210M AUM
Fischer Investment Strategies
Fischer Investment Strategies Westlake Village, California $210M AUM 28.93% 1-Year Est. Return
Arcadia Wealth Management (New York)
Arcadia Wealth Management (New York) Smithtown, New York $210M AUM 25.07% 1-Year Est. Return
IF
Integrity Financial Cheyenne, Wyoming $209M AUM 21.37% 1-Year Est. Return
Beckerman Institutional
Beckerman Institutional Ocean Grove, New Jersey $210M AUM 18.74% 1-Year Est. Return
Three Cord True Wealth Management
Three Cord True Wealth Management Beaver, Pennsylvania $210M AUM 21.9% 1-Year Est. Return
Aristotle Pacific Capital
Aristotle Pacific Capital Newport Beach, California $210M AUM 2.03% 1-Year Est. Return
Humankind Investments
Humankind Investments New York $209M AUM 26.41% 1-Year Est. Return

Catalys Pacific's Q3 2026 Portfolio in Review

As of Q3 2026, Catalys Pacific held 2 positions worth $210M, down 8.6% from $229M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2026: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific added most to Phathom Pharmaceuticals in Q3 2026, an estimated $3.66M increase.
  • Catalys Pacific's biggest Q3 2026 reduction was Mineralys Therapeutics, cutting an estimated $2.84M.
  • Catalys Pacific's ten largest holdings make up 100% of its $210M portfolio in Q3 2026.
  • Catalys Pacific opened 0 new positions and closed 0 in Q3 2026.
  • Catalys Pacific's portfolio value fell 8.6% quarter-over-quarter to $210M.

Based on Catalys Pacific's 13F filing for Q3 2026, filed 30 Oct 2026.